52 related articles for article (PubMed ID: 36402713)
1. Bladder cancer is associated with decreased urinary microbiota diversity and alterations in microbial community composition.
Hrbáček J; Tláskal V; Čermák P; Hanáček V; Zachoval R
Urol Oncol; 2023 Feb; 41(2):107.e15-107.e22. PubMed ID: 36402713
[TBL] [Abstract][Full Text] [Related]
2. Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China.
Wu P; Zhang G; Zhao J; Chen J; Chen Y; Huang W; Zhong J; Zeng J
Front Cell Infect Microbiol; 2018; 8():167. PubMed ID: 29904624
[TBL] [Abstract][Full Text] [Related]
3. Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study.
Chipollini J; Wright JR; Nwanosike H; Kepler CY; Batai K; Lee BR; Spiess PE; Stewart DB; Lamendella R
Urol Oncol; 2020 Jul; 38(7):615-621. PubMed ID: 32414567
[TBL] [Abstract][Full Text] [Related]
4. The Potential Role of Urinary Microbiota in Bladder Carcinogenesis: A Systematic Review.
Ghabousian A; Shafigh A; Tayebi S; Salehi-Pourmehr H; Mostafaei H; Lemberger U; Mori K; Sadeghi-Ghyassi F; Hassanzadeh H; Hajebrahimi S; Shariat SF
Urol J; 2024 Jun; 21(4):208-220. PubMed ID: 38716613
[TBL] [Abstract][Full Text] [Related]
5. Studying the urine microbiome in superficial bladder cancer: samples obtained by midstream voiding versus cystoscopy.
Hourigan SK; Zhu W; S W Wong W; Clemency NC; Provenzano M; Vilboux T; Niederhuber JE; Deeken J; Chung S; McDaniel-Wiley K; Trump D
BMC Urol; 2020 Jan; 20(1):5. PubMed ID: 31992287
[TBL] [Abstract][Full Text] [Related]
6. Urinary catheter-associated microbiota change in accordance with treatment and infection status.
Bossa L; Kline K; McDougald D; Lee BB; Rice SA
PLoS One; 2017; 12(6):e0177633. PubMed ID: 28628622
[TBL] [Abstract][Full Text] [Related]
7. The impact of urine collection method on canine urinary microbiota detection: a cross-sectional study.
Coffey EL; Gomez AM; Ericsson AC; Burton EN; Granick JL; Lulich JP; Furrow E
BMC Microbiol; 2023 Apr; 23(1):101. PubMed ID: 37055748
[TBL] [Abstract][Full Text] [Related]
8. Current Trends and Challenges of Microbiome Research in Bladder Cancer.
Isali I; Helstrom EK; Uzzo N; Lakshmanan A; Nandwana D; Valentine H; Sindhani M; Abbosh P; Bukavina L
Curr Oncol Rep; 2024 Mar; 26(3):292-298. PubMed ID: 38376627
[TBL] [Abstract][Full Text] [Related]
9. Cataloging the phylogenetic diversity of human bladder bacterial isolates.
Du J; Khemmani M; Halverson T; Ene A; Limeira R; Tinawi L; Hochstedler-Kramer BR; Noronha MF; Putonti C; Wolfe AJ
Genome Biol; 2024 Mar; 25(1):75. PubMed ID: 38515176
[TBL] [Abstract][Full Text] [Related]
10. Bladder Cancer and the Urinary Microbiome-New Insights and Future Directions: A Review.
Russo AE; Memon A; Ahmed S
Clin Genitourin Cancer; 2024 Apr; 22(2):434-444. PubMed ID: 38220540
[TBL] [Abstract][Full Text] [Related]
11. Oral microbial community composition is associated with pancreatic cancer: A case-control study in Iran.
Vogtmann E; Han Y; Caporaso JG; Bokulich N; Mohamadkhani A; Moayyedkazemi A; Hua X; Kamangar F; Wan Y; Suman S; Zhu B; Hutchinson A; Dagnall C; Jones K; Hicks B; Shi J; Malekzadeh R; Abnet CC; Pourshams A
Cancer Med; 2020 Jan; 9(2):797-806. PubMed ID: 31750624
[TBL] [Abstract][Full Text] [Related]
12. Uncovering Microbial Composition of the Tissue Microenvironment in Bladder Cancer using RNA Sequencing Data.
Yao R; Ai B; Wang Z; Shen B; Xue G; Yu D
J Cancer; 2024; 15(8):2431-2441. PubMed ID: 38495492
[No Abstract] [Full Text] [Related]
13. Microbiome Sex-Related Diversity in Non-Muscle-Invasive Urothelial Bladder Cancer.
Bilski K; Żeber-Lubecka N; Kulecka M; Dąbrowska M; Bałabas A; Ostrowski J; Dobruch A; Dobruch J
Curr Issues Mol Biol; 2024 Apr; 46(4):3595-3609. PubMed ID: 38666955
[TBL] [Abstract][Full Text] [Related]
14. Research progress on the microbiota in bladder cancer tumors.
Lou K; Chi J; Wu J; Ma J; Liu S; Cui Y
Front Cell Infect Microbiol; 2024; 14():1374944. PubMed ID: 38650736
[TBL] [Abstract][Full Text] [Related]
15. Urinary Microbiome Dysbiosis and Immune Dysregulations as Potential Diagnostic Indicators of Bladder Cancer.
Uzelac M; Xin R; Chen T; John D; Li WT; Rajasekaran M; Ongkeko WM
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254883
[TBL] [Abstract][Full Text] [Related]
16. Genetically proxied intestinal microbiota and risk of bladder cancer.
Zhang F; Yao Z; Zhang B
Int J Surg; 2024 Mar; 110(3):1857-1859. PubMed ID: 38181112
[No Abstract] [Full Text] [Related]
17. A commentary on "Genetically proxied intestinal microbiota and risk of bladder cancer".
Zhu X; He J; Chen J
Int J Surg; 2024 Jun; ():. PubMed ID: 38857505
[No Abstract] [Full Text] [Related]
18. Microbiota of Urine, Glans and Prostate Biopsies in Patients with Prostate Cancer Reveals a Dysbiosis in the Genitourinary System.
Gonçalves MFM; Pina-Vaz T; Fernandes ÂR; Miranda IM; Silva CM; Rodrigues AG; Lisboa C
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900215
[TBL] [Abstract][Full Text] [Related]
19. Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon-degrading Bacteria Among Bladder Cancer Patients.
Bukavina L; Isali I; Ginwala R; Sindhani M; Calaway A; Magee D; Miron B; Correa A; Kutikov A; Zibelman M; Ghannoum M; Retuerto M; Ponsky L; Markt S; Uzzo R; Abbosh P
Eur Urol Oncol; 2023 Apr; 6(2):190-203. PubMed ID: 36868921
[TBL] [Abstract][Full Text] [Related]
20. The regulation of intestinal flora on host's genes may play an essential role in the development of endometrial hyperplastic processes in yang deficiency individuals.
Zhang HX; Zhao XL; Wu HX; Luo ZQ; Wang LM; Lv SR; Huang XR; Dong N; Li DZ; Bao C; Su LD; Liu YX; Hu HQ; Bu ZX; Zhang HR; Liu Y; Chang SJ; He ZY; Sai L; Wang HW; Guo HM; Huang XH; Cao X
Int J Clin Exp Pathol; 2024; 17(4):121-136. PubMed ID: 38716350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
